Johnson & Johnson News and Activities

Presence

Johnson & Johnson makes medicines and medical technology products for disease treatment, surgery, and patient care. It serves hospitals, healthcare professionals, and patients in markets around the world.

Johnson & Johnson products and services overview:

  • Prescription medicines
  • Cancer treatments
  • Immunology therapies
  • Surgical devices
  • Orthopedic products
  • Vision care
  • Cardiovascular devices

Revenue: ~$89 billion

Employees: 138,000

Headquarters: New Brunswick, United States (USA)


Johnson & Johnson is one of the...

Johnson & Johnson is a company listed under the stock ticker JNJ (US).

Johnson & Johnson has a direct presence in 23 countries.

Johnson & Johnson has 56 subsidiaries including Abiomed, DePuy Synthes and Ethicon.

They are in:

Acquisition, funding and merger involving Johnson & Johnson.

Executives

View the org chart displaying its 420 main executives

Most searched biographies at Johnson & Johnson
Popular executive movements at Johnson & Johnson
  • Ryan Koors will join the company as Vice President, Investor Relations on May 6, 2026  (posted on April 30 2026).
  • Lauren Johnson, who was Senior Director, Investor Relations, is promoted to Chief Financial Officer, External Innovation Finance  (posted on February 26 2026).
  • Geetanjali Gamel, who was Head of Human Resources, Global Commercial Strategy and Business Development, is promoted to Head of Human Resources, US Surgery  (posted on January 5 2026).

Click here to view some more movements at Johnson & Johnson

Create your alert
to follow the executive moves at Johnson & Johnson.

News

Press releases by Johnson & Johnson
Social media about Johnson & Johnson

The best decision-maker directory

Companies

Companies

Discover the organization charts of your favorite companies.

Executives

Executives

Spot the influential executives using our search tools.

Alerts

Alerts

Receive notifications when executive positions change.

Customers

Real-time

Fuel your company's success with our real-time data.